CA2883221C - Benzofurazan anti-amyloid compounds and methods - Google Patents

Benzofurazan anti-amyloid compounds and methods Download PDF

Info

Publication number
CA2883221C
CA2883221C CA2883221A CA2883221A CA2883221C CA 2883221 C CA2883221 C CA 2883221C CA 2883221 A CA2883221 A CA 2883221A CA 2883221 A CA2883221 A CA 2883221A CA 2883221 C CA2883221 C CA 2883221C
Authority
CA
Canada
Prior art keywords
mmol
et0ac
added
reaction
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2883221A
Other languages
English (en)
French (fr)
Other versions
CA2883221A1 (en
Inventor
Mark A. Reed
Thomas K. Wood
Scott C. Banfield
Christopher J. Barden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Treventis Corp
Original Assignee
Treventis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treventis Corp filed Critical Treventis Corp
Publication of CA2883221A1 publication Critical patent/CA2883221A1/en
Application granted granted Critical
Publication of CA2883221C publication Critical patent/CA2883221C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B36/00—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
    • E21B36/001—Cooling arrangements
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B36/00—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
    • E21B36/003—Insulating arrangements
    • E—FIXED CONSTRUCTIONS
    • E21—EARTH OR ROCK DRILLING; MINING
    • E21B—EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS
    • E21B36/00—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones
    • E21B36/04—Heating, cooling or insulating arrangements for boreholes or wells, e.g. for use in permafrost zones using electrical heaters
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L11/00—Hoses, i.e. flexible pipes
    • F16L11/20—Double-walled hoses
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L53/00—Heating of pipes or pipe systems; Cooling of pipes or pipe systems
    • F16L53/30—Heating of pipes or pipe systems
    • F16L53/35—Ohmic-resistance heating
    • F16L53/38—Ohmic-resistance heating using elongate electric heating elements, e.g. wires or ribbons
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L9/00—Rigid pipes
    • F16L9/18—Double-walled pipes; Multi-channel pipes or pipe assemblies
    • F16L9/19—Multi-channel pipes or pipe assemblies
    • F16L9/20—Pipe assemblies
    • H—ELECTRICITY
    • H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02G—INSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
    • H02G3/00—Installations of electric cables or lines or protective tubing therefor in or on buildings, equivalent structures or vehicles
    • H02G3/36—Installations of cables or lines in walls, floors or ceilings
    • H02G3/38—Installations of cables or lines in walls, floors or ceilings the cables or lines being installed in preestablished conduits or ducts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Mining & Mineral Resources (AREA)
  • General Engineering & Computer Science (AREA)
  • Fluid Mechanics (AREA)
  • Geochemistry & Mineralogy (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Environmental & Geological Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Architecture (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Laying Of Electric Cables Or Lines Outside (AREA)
CA2883221A 2012-08-24 2013-08-22 Benzofurazan anti-amyloid compounds and methods Active CA2883221C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261693011P 2012-08-24 2012-08-24
US61/693,011 2012-08-24
PCT/US2013/056220 WO2014031873A2 (en) 2012-08-24 2013-08-22 Benzofurazan anti-amyloid compounds and methods

Publications (2)

Publication Number Publication Date
CA2883221A1 CA2883221A1 (en) 2014-02-27
CA2883221C true CA2883221C (en) 2020-01-21

Family

ID=50150397

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2883221A Active CA2883221C (en) 2012-08-24 2013-08-22 Benzofurazan anti-amyloid compounds and methods

Country Status (14)

Country Link
US (2) US9328078B2 (enExample)
EP (1) EP2888252B1 (enExample)
JP (1) JP6219955B2 (enExample)
KR (1) KR102046499B1 (enExample)
CN (1) CN104768949A (enExample)
AU (1) AU2013305663B2 (enExample)
BR (1) BR112015003824B1 (enExample)
CA (1) CA2883221C (enExample)
IL (1) IL237305B (enExample)
MX (1) MX365851B (enExample)
NZ (1) NZ705167A (enExample)
RU (1) RU2641293C2 (enExample)
WO (2) WO2014031873A2 (enExample)
ZA (1) ZA201501161B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20191150T1 (hr) * 2014-02-27 2019-10-04 Treventis Corporation Antiamiloidni spojevi koji sadrže benzofuran
DE102014214687A1 (de) * 2014-07-25 2016-01-28 Contitech Techno-Chemie Gmbh Beheizbarer Schlauch
WO2018225087A1 (en) * 2017-06-06 2018-12-13 Council Of Scientific And Industrial Research Cobalt complexes, process for preparation and use thereof
CN108566693B (zh) * 2017-11-27 2020-12-25 安邦电气股份有限公司 一种高效率伴热带
CN108235475B (zh) * 2017-11-27 2021-01-22 安邦电气股份有限公司 一种便于使用的伴热带
US20230365516A1 (en) * 2020-07-14 2023-11-16 Washington University Compounds for cancer therapy and imaging

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971416A (en) * 1974-08-16 1976-07-27 Thermon Manufacturing Company Preinsulated pipe assembly and pipeline
DE19643037A1 (de) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
JP2002228081A (ja) * 2001-02-06 2002-08-14 Nitta Moore Co 保温・移送用配管
JP2005511625A (ja) * 2001-11-14 2005-04-28 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 向精神薬としてのピラゾール誘導体
JP2003328402A (ja) * 2002-05-16 2003-11-19 Sekisui Chem Co Ltd ヒータ挿入ガイド付き管
GB0228410D0 (en) * 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds
JP2004244958A (ja) * 2003-02-14 2004-09-02 Sekisui Chem Co Ltd 凍結防止用流水配管
GB0328900D0 (en) * 2003-12-12 2004-01-14 Glaxo Group Ltd Novel compounds
WO2006002284A1 (en) 2004-06-22 2006-01-05 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
GB2423811A (en) * 2005-03-02 2006-09-06 Valpar Ind Ltd Improved Beverage Python
CA2735158C (en) * 2008-08-29 2016-11-08 Treventis Corporation Compositions and methods of treating amyloid disease
JP5937102B2 (ja) * 2010-12-14 2016-06-22 エレクトロフォレティクス リミテッド カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤

Also Published As

Publication number Publication date
US20150266838A1 (en) 2015-09-24
WO2014031873A3 (en) 2014-04-17
KR102046499B1 (ko) 2019-11-19
MX2015002418A (es) 2015-09-21
WO2014031873A2 (en) 2014-02-27
RU2641293C2 (ru) 2018-01-17
NZ705167A (en) 2017-12-22
MX365851B (es) 2019-06-17
US9328078B2 (en) 2016-05-03
BR112015003824B1 (pt) 2022-10-04
IL237305A0 (en) 2015-04-30
BR112015003824A2 (pt) 2018-05-29
EP2888252B1 (en) 2017-06-07
KR20150046263A (ko) 2015-04-29
CN104768949A (zh) 2015-07-08
WO2014031942A1 (en) 2014-02-27
CA2883221A1 (en) 2014-02-27
RU2015110256A (ru) 2016-10-10
ZA201501161B (en) 2016-06-29
JP6219955B2 (ja) 2017-10-25
IL237305B (en) 2018-08-30
US20160264535A1 (en) 2016-09-15
AU2013305663B2 (en) 2017-11-02
EP2888252A4 (en) 2016-01-06
JP2015526475A (ja) 2015-09-10
EP2888252A2 (en) 2015-07-01
AU2013305663A1 (en) 2015-03-05

Similar Documents

Publication Publication Date Title
CA2883221C (en) Benzofurazan anti-amyloid compounds and methods
TWI485150B (zh) 三唑并吡啶化合物及其作為脯胺醯基羥化酶抑制劑或紅血球生成素生產誘導劑之作用
ES2239595T3 (es) Derivados de 4,5,6,7-tetrahidroindazol como agentes antitumorales.
US20050171101A1 (en) Phenanthridinones as parp inhibitors
CN105120860B (zh) 组蛋白脱乙酰酶抑制剂
EP3590920B1 (en) 2-(substituted benzene matrix) aromatic formate fto inhibitor, preparation method therefor, and applications thereof
WO2020114482A1 (zh) 一类异吲哚啉类化合物、其制备方法、药物组合物及其应用
CN107530350A (zh) 细胞坏死抑制剂及相关方法
CA2888480A1 (en) Heteroaryl linked quinolinyl modulators of ror.gamma.t
CA2965512A1 (en) Trifluoromethyl alcohols as modulators of ror.gamma.t
US20220112218A1 (en) Methods and materials for increasing transcription factor eb polypeptide levels
JPH11349572A (ja) 新規アミド誘導体およびその塩
WO2011078360A1 (ja) アミド化合物
US20150225424A1 (en) Antibacterial compounds
JP6927959B2 (ja) ベンジリデングアニジン誘導体と化学療法剤の併用による癌の治療方法
CA2977360C (en) Anti-amyloid compounds containing benzofurazan
CA2868930A1 (en) Pyrimidine derivatives for the treatment of bacterial diseases
WO2006078037A1 (ja) チアゾリジンジオン化合物の製造方法及びその製造中間体
JP4030683B2 (ja) ベンズアミド誘導体の合成法
WO2010059555A1 (en) Prolyl hydroxylase inhibitors
CA2367899A1 (en) Triazolopyrimidinol compounds and salts thereof
GB2386893A (en) (4-Aroylpyrrol-2-yl)methylene substituted azole & azine derivatives and their therapeutic use as antibacterials

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180227